How much do paid clinical trials in Binghamton pay?

Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.

How do I join a study in Binghamton, NY?

Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.

Is compensation for clinical trials taxable?

In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.

What is the difference between a research center and a hospital study in Binghamton?

Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.

Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Binghamton typically complete one or two studies per year.

Paid Clinical Trials Binghamton, NY — 18 Studies Recruiting (Jul 2026)

Paid Clinical Trials in Binghamton, NY

Studies commonly pay $75 to $4,500 per completed study

18 clinical trials are currently recruiting participants within 30 miles of Binghamton. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

18studies recruiting

2+research centers nearby

6condition categories

Live from the NIH registry

Studies recruiting near Binghamton right now

Top 18 of 18 recruiting studies, sorted by proximity — each links to its official registry page

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma Phase 3 Interventional 1,450 participants sought

Lourdes Hospital — Binghamton, New York (0.5 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

See eligibility & contact on ClinicalTrials.gov (NCT04566328)

Contextual Word Learning in Children With Developmental Language Disorder

Developmental Language Disorder N/A Interventional 100 participants sought

Decker College of Nursing and Health Sciences, Health Sciences Building — Johnson City, New York (2.7 mi) · Sponsor: Binghamton University

See eligibility & contact on ClinicalTrials.gov (NCT05988190)

A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC

Non-Small Cell Lung Cancer Phase 3 Interventional 860 participants sought

Research Site — Johnson City, New York (2.7 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT05211895)

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought

Lourdes Hospital — Binghamton, New York (0.5 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT04852887)

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

Acute Coronary Syndrome Phase 3 Interventional 2,000 participants sought

Research Site — Johnson City, New York (2.7 mi) · Sponsor: DalCor Pharmaceuticals

See eligibility & contact on ClinicalTrials.gov (NCT05918861)

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Breast Cancer N/A Observational 30,000 participants sought

Broome Oncology — Binghamton, New York (0.5 mi) · Sponsor: Agendia

See eligibility & contact on ClinicalTrials.gov (NCT03053193)

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Lung Cancer Diagnosis N/A Observational 20,000 participants sought

Our Lady of Lourdes Hospital — Binghamton, New York (0.5 mi) · Sponsor: Freenome Holdings Inc.

See eligibility & contact on ClinicalTrials.gov (NCT06122077)

Physical Activity: Feasibility Study

Obesity, Physical Activity N/A Interventional 30 participants sought

Guthrie — Binghamton, New York (0.5 mi) · Sponsor: Binghamton University

See eligibility & contact on ClinicalTrials.gov (NCT05935111)

Comparison of Smartphone and Community-Based Delivery of the Otago Exercise Program for Fall Risk in Older Adults

Frail Elderly, Fall N/A Interventional 30 participants sought

Binghamton University — Binghamton, New York (0.5 mi) · Sponsor: Binghamton University

See eligibility & contact on ClinicalTrials.gov (NCT07433153)

Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease

Diabetic Kidney Disease (DKD) Phase 2 Interventional 270 participants sought

Velocity Clinical Research — Binghamton, New York (0.5 mi) · Sponsor: Regeneron Pharmaceuticals

See eligibility & contact on ClinicalTrials.gov (NCT07271186)

The Lily Device Trial

Chemotherapy Induced Alopecia N/A Interventional 85 participants sought

Guthrie - Our Lady of Lourdes Memorial Hospital — Binghamton, New York (0.5 mi) · Sponsor: Luminate Medical, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT06786078)

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

COPD (Chronic Obstructive Pulmonary Disease) Phase 3 Interventional 5,250 participants sought

Research Site — Vestal, New York (7.5 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT06283966)

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Atherosclerotic Cardiovascular Disease, Overweight Phase 3 Interventional 12,800 participants sought

Velocity Clinical Research - Binghamton — Binghamton, New York (0.5 mi) · Sponsor: Amgen

See eligibility & contact on ClinicalTrials.gov (NCT07037433)

Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

Malignant Solid Neoplasm N/A Observational 2,062 participants sought

Lourdes Hospital — Binghamton, New York (0.5 mi) · Sponsor: SWOG Cancer Research Network

See eligibility & contact on ClinicalTrials.gov (NCT04871542)

Development of Attentional Biases for Affective Cues in Infants of Mothers With Depression

Depression - Major Depressive Disorder N/A Interventional 225 participants sought

Binghamton University — Binghamton, New York (0.5 mi) · Sponsor: Binghamton University

See eligibility & contact on ClinicalTrials.gov (NCT06835855)

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

Asthma Phase 3 Interventional 440 participants sought

Research Site — Vestal, New York (7.5 mi) · Sponsor: AstraZeneca

See eligibility & contact on ClinicalTrials.gov (NCT06307665)

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Diabetes Mellitus, Type 2, Hypertension Phase 3 Interventional 11,800 participants sought

Velocity Clinical Research - Binghamton — Binghamton, New York (0.5 mi) · Sponsor: Boehringer Ingelheim

See eligibility & contact on ClinicalTrials.gov (NCT07064473)

Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects

Malignancy N/A Observational 240 participants sought

Lourdes Hospital — Binghamton, New York (0.5 mi) · Sponsor: Alliance for Clinical Trials in Oncology

See eligibility & contact on ClinicalTrials.gov (NCT04242095)

Clinical trials in Binghamton: what's recruiting

The Binghamton area currently has 18 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Binghamton, the most active research areas are:

Cancer & Oncology5 studies

Diabetes & Metabolism4 studies

Lungs & Breathing2 studies

Heart & Vascular2 studies

Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Binghamton, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Binghamton

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Binghamton participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.